RSSIn May of 2012, John Eastman interviewed Tim Ruane, CEO of InSite Vision (INSV). Their discussion spanned the CEO’s experience in maneuvering in and out of the FDA, clinical trials, managing approved assets, and the CEO’s pragmatic approach towards medical fields and drug commercialization. Below is the first segment of that interview, discussing the 47 [...]
(more→)
